Price T Rowe Associates Inc ENLIVEN THERAPEUTICS INC Transaction History

Price T Rowe Associates Inc

  • $883 Billion
  • Q2 2025
Number of Shares
528,250
Previous 16,160 3168.87%
Holding current value
$10.6 Million
Previous $319,000 3221.94%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
512,090 Added 3168.87%
528,250 $10.6 Million
Q1 2025

May 14, 2025
BUY
N/A
2,533 Added 18.59%
16,160 $319,000
Q4 2024

Feb 14, 2025
BUY
N/A
1,980 Added 17.0%
13,627 $307,000
Q3 2024

Nov 14, 2024
BUY
N/A
440 Added 3.93%
11,647 $298,000
Q2 2024

Aug 14, 2024
BUY
N/A
11,207 New
11,207 $262,000
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email